1-37557607-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003462.5(DNALI1):c.86G>A(p.Arg29Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000105 in 1,612,326 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R29W) has been classified as Uncertain significance.
Frequency
Consequence
NM_003462.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DNALI1 | NM_003462.5 | c.86G>A | p.Arg29Gln | missense_variant | 2/6 | ENST00000652629.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DNALI1 | ENST00000652629.1 | c.86G>A | p.Arg29Gln | missense_variant | 2/6 | NM_003462.5 | P1 | ||
DNALI1 | ENST00000296218.8 | c.152G>A | p.Arg51Gln | missense_variant | 2/6 | 1 | |||
DNALI1 | ENST00000466723.1 | n.83G>A | non_coding_transcript_exon_variant | 2/4 | 2 | ||||
DNALI1 | ENST00000490312.1 | n.128G>A | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152020Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000281 AC: 7AN: 249090Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134772
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1460306Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 726460
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152020Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74246
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 25, 2023 | The c.152G>A (p.R51Q) alteration is located in exon 2 (coding exon 2) of the DNALI1 gene. This alteration results from a G to A substitution at nucleotide position 152, causing the arginine (R) at amino acid position 51 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at